Amalgamated Bank Has $753,000 Stock Holdings in Sotera Health (NASDAQ:SHC)

Amalgamated Bank trimmed its stake in Sotera Health (NASDAQ:SHC) by 7.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,436 shares of the company’s stock after selling 5,173 shares during the quarter. Amalgamated Bank’s holdings in Sotera Health were worth $753,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. CWM LLC raised its stake in Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after acquiring an additional 993 shares during the period. Swiss National Bank lifted its stake in shares of Sotera Health by 0.5% during the 1st quarter. Swiss National Bank now owns 195,900 shares of the company’s stock worth $2,353,000 after buying an additional 1,000 shares during the last quarter. TD Asset Management Inc lifted its stake in shares of Sotera Health by 1.5% during the 2nd quarter. TD Asset Management Inc now owns 123,454 shares of the company’s stock worth $1,465,000 after buying an additional 1,800 shares during the last quarter. Securian Asset Management Inc. boosted its holdings in shares of Sotera Health by 23.0% during the 1st quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock worth $122,000 after buying an additional 1,900 shares during the period. Finally, State of Alaska Department of Revenue grew its stake in Sotera Health by 20.6% in the 1st quarter. State of Alaska Department of Revenue now owns 13,490 shares of the company’s stock valued at $162,000 after buying an additional 2,300 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Trading Up 1.0 %

Shares of Sotera Health stock opened at $16.76 on Friday. The firm’s 50-day moving average price is $15.17 and its two-hundred day moving average price is $12.93. The company has a market capitalization of $4.75 billion, a price-to-earnings ratio of 88.22 and a beta of 2.07. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The business had revenue of $277.00 million for the quarter, compared to analysts’ expectations of $266.45 million. During the same period last year, the firm posted $0.19 earnings per share. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, analysts forecast that Sotera Health will post 0.64 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have issued reports on SHC shares. Royal Bank of Canada restated an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research report on Tuesday, August 6th. Barclays boosted their price target on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research note on Tuesday, August 6th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $15.70.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the transaction, the director now owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 55.12% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.